DARATUMUMAB; HYALURONIDASE (dar a toom ue mab / hye al ur ON i dase) is a monoclonal antibody. Hyaluronidase is used to improve the effects of daratumumab. It treats certain types of cancer. Some of the cancers treated are multiple myeloma and light-chain amyloidosis.
|
DARATUMUMAB; HYALURONIDASE (dar a toom ue mab / hye al ur ON i dase) is a monoclonal antibody. Hyaluronidase is used to improve the effects of daratumumab. It treats certain types of cancer. Some of the cancers treated are multiple myeloma and light-chain amyloidosis.
|
|
DASATINIB (da SA ti nib) is a medicine that targets specific proteins in cancer cells and stops the cancer cells from growing. It is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia.
|
DASATINIB (da SA ti nib) is a medicine that targets specific proteins in cancer cells and stops the cancer cells from growing. It is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia.
|
|
NORETHINDRONE; ETHINYL ESTRADIOL (nor eth IN drone; ETH in il es tra DYE ole) is an oral contraceptive. The products combine two types of female hormones, an estrogen and a progestin. These products prevent ovulation and pregnancy.
|
NORETHINDRONE; ETHINYL ESTRADIOL (nor eth IN drone; ETH in il es tra DYE ole) is an oral contraceptive. The products combine two types of female hormones, an estrogen and a progestin. These products prevent ovulation and pregnancy.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
DAUNORUBICIN (daw noe ROO bi sin) is a chemotherapy drug. This medicine is used to treat acute leukemias.
|
DAUNORUBICIN (daw noe ROO bi sin) is a chemotherapy drug. This medicine is used to treat acute leukemias.
|
|
GLASDEGIB (glas deg ib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat acute myelogenous leukemia.
|
GLASDEGIB (glas deg ib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat acute myelogenous leukemia.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|
There is no additional information on this drug.
|
There is no additional information on this drug.
|
|